These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8397681)

  • 1. Technological testing of calcium carbonate tablets for use in the treatment of renal osteodystrophy.
    Dal Zotto M; Ragazzi E; Realdon N; Dalla Fini G
    Farmaco; 1993 Jul; 48(7):989-1005. PubMed ID: 8397681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of calcium carbonate in the treatment of renal osteodystrophy].
    Morinière P; Boudailliez B; Westeel PF; Achard JM; Djerad M; Nahle M; Amar M; Fournier A
    Nephrologie; 1991; 12(1):31-41. PubMed ID: 2034319
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effects of CaCO3 on renal osteodystrophy--comparison of patients with chronic renal failure in the predialytic stage and patients undergoing maintenance hemodialysis].
    Okada K; Kuno T; Yanai M; Maeda H; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):1053-62. PubMed ID: 3244188
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of pH on in vitro disintegration of phosphate binders.
    Stamatakis MK; Alderman JM; Meyer-Stout PJ
    Am J Kidney Dis; 1998 Nov; 32(5):808-12. PubMed ID: 9820451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable efficacy of calcium carbonate tablets.
    Kobrin SM; Goldstein SJ; Shangraw RF; Raja RM
    Am J Kidney Dis; 1989 Dec; 14(6):461-5. PubMed ID: 2596473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoride and dialysis osteodystrophy: results of a double-blind study.
    Oreopoulos DG; Taves DR; Rabinovich S; Meema HE; Murray T; Fenton SS; deVeber GA
    Trans Am Soc Artif Intern Organs; 1974; 20A():203-8. PubMed ID: 4615422
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of quick disintegrating calcium carbonate tablets.
    Fausett H; Gayser C; Dash AK
    AAPS PharmSciTech; 2000 Jul; 1(3):E20. PubMed ID: 14727906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current treatment of renal osteodystrophy in children].
    Macher MA; Baudouin V; Akil R; Loirat C
    Arch Pediatr; 1997; 4(2 Suppl 2):91s-94s. PubMed ID: 9246312
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of renal osteodystrophy: physiopathology and secondary effects].
    Haldimann B; Flury W
    Schweiz Med Wochenschr; 1977 Aug; 107(32):1113-8. PubMed ID: 333572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumer vinegar test for determining calcium disintegration.
    Mason NA; Patel JD; Dressman JB; Shimp LA
    Am J Hosp Pharm; 1992 Sep; 49(9):2218-22. PubMed ID: 1524066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and prevention of uremic osteodystrophy.
    Giovannetti S; Barsotti G; Gretz N; Kraft K
    Contrib Nephrol; 1989; 72():66-72. PubMed ID: 2743774
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcitriol and calcium carbonate therapy in early chronic renal failure.
    Fournier A
    Nephrol Dial Transplant; 1995; 10(4):577. PubMed ID: 7624009
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium carbonate and magnesium hydroxide in the prevention of renal osteodystrophy or the demise of aluminum toxicity in uremia. Analysis of 5 years experience.
    Morinière P; Fournier A; Westeel PF; Idrissi A; Renaud H; Hocine C; Belbrik S; Marie A; Leflon P; Sebert JL
    Contrib Nephrol; 1988; 64():58-73. PubMed ID: 3053039
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of in vitro and in vivo tests for determination of availability of calcium from calcium carbonate tablets.
    Whiting SJ; Pluhator MM
    J Am Coll Nutr; 1992 Oct; 11(5):553-60. PubMed ID: 1452954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of binder type and concentration on the physical characteristics of calcium carbonate granules and their corresponding tablets.
    Elsabbagh HM; Ghanem AH; Abdel-Alim HM
    Pharmazie; 1981 Aug; 36(8):548-51. PubMed ID: 7291287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitriol and calcium carbonate therapy in early chronic renal failure.
    Bianchi ML; Colantonio G; Campanini F; Rossi R; Valenti G; Ortolani S; Buccianti G
    Nephrol Dial Transplant; 1994; 9(11):1595-9. PubMed ID: 7870349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The radiographic spectrum of renal osteodystrophy.
    Molpus WM; Pritchard RS; Walker CW; Fitzrandolph RL
    Am Fam Physician; 1991 Jan; 43(1):151-8. PubMed ID: 1986484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The possible use of bisphosphonates in the treatment of renal osteodystrophy.
    Malluche HH
    Clin Nephrol; 1992; 38 Suppl 1():S87-91. PubMed ID: 1295713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
    Bordier PJ; Marie PJ; Arnaud CD
    Kidney Int Suppl; 1975 Jan; (2):102-12. PubMed ID: 1057669
    [No Abstract]   [Full Text] [Related]  

  • 20. [High doses of calcium carbonate or the combination of 1 alpha hydroxylated derivatives of vitamin D and aluminum compounds bound to phosphorus in the preventive treatment of renal osteodystrophy].
    Fournier A; Morinière P; Boudailliez B; Marie A; Westeel PF; Renaud M; Belbrik S; Hocine C; Sebert JL
    Presse Med; 1988 Apr; 17(16):777-80. PubMed ID: 2968564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.